Evidence from NCBI research highlights that anabolic and corticosteroids alter lipid profiles, blood pressure, and myocardial structure, raising risks of arrhythmia and cardiac arrest. These pathological changes accelerate heart failure progression, even in younger users. Clinical oversight and preventive monitoring remain critical to balance therapeutic value with cardiovascular safety.